From: Infection dynamics and persistence of hepatitis E virus on pig farms – a review
Reference | Additional information about article | Route of infection | HEV inoculation dose | Latent period (days) | Duration of fecal shedding (days) | Period between exposure and seroconversion (days) |
---|---|---|---|---|---|---|
Satou et al. [9] | Modelled data from Halbur et al. [3] | IV | 104.5 PI50 | < 7 a | > 7; < 27 a | 25.0 (95% CI: 20.9–31.3) |
Dähnert et al. [10] | Experiment to find minimal infectious dose of HEV in pigs | IV | 9,4 * 10 5 copies | range: 9–15 | 3/4 pigs: 7 (+ − 2.7) | 17 |
9,9 * 10 4 copies | 15 | 1/4 pigs: 9 | 23 | |||
4,0 * 10 3 copies | range: 17–23 | no viral clearance seen b | 27 | |||
7,2 * 10 3 copies | range: 17–30 | no viral clearance 74–61 days after shedding started b | 27 | |||
6,5 * 10 2 copies | range: 27–30 | no viral clearance seen, minimally 18 days b | 37 | |||
6,5 * 10 1 copies | range: 21–37 | 3/4 pigs: range: 11–28 | 27 | |||
6,5 copies | range: 37–62 | no viral clearance seen b | 58 | |||
Bouwknegt et al. [11] | Block 1 | IV | 2*104 PCR d.u. | 3 (range: 2–7) | 49 (95% CI 17–141) d | NA |
Contact | Unknown | 9 c | NA | |||
Block 2 | IV | 1*104 PCR d.u. | 3 (range: 2–7) | 13 (95% CI 11–17) d | NA | |
Contact | Unknown | 17 c | NA | |||
Bouwknegt et al. [12] | IV | 1*104 PCR d.u. | 3.2 (95% CI 2.0–4.3) | 39.9 (95% CI 27.7–52.1) | 15.7 e | |
Contact | Unknown | 7.2 (95% CI 4.8–9.6) | 23.3 (95% CI 18.7–27.9) | 20.2 e | ||
Casas et al. [13] | No info about PRRSV status of pigs | Oral | 2*105 GEs | 22 / 25 f | NA | 57 g |
Andraud et al. [14] | Oral | 1*109 GEs | 6.9 (95% cred. int. 5.8–7.9) | 9.7 (95% cred. int. 8.2–11.3) | 26.3 (95% cred. int. 23.5–29.5) h | |
Contact | Unknown | 7.1 (95% cred. int. 3.2–12.3) | ||||
Salines et al. [15] | PRRSV coinfected. ~ Same study design as Andraud et al. 2013 | Oral | 1*108 GEs | 12.9 (95% cred. int. 12.8–14.4) | 48.6 (95% cred. int. 27.9–84.6) | 43.1 (95% cred. int.: 35.7–52.2) |
Contact | Unknown | 13.4 (95% cred. int. 8.6–17.1) | ||||
Salines et al. [16] | One group of HEV only and one of HEV/PCV2 coinfected pigs | Oral (HEV only) | 1*107 GEs | 12.3 (95% cred. int. 4.4–25.5) | NA | 25.6 (95% cred. int.: 19.3–33.8) |
Oral (HEV/PCV2) | 1*107 GEs | 11.6 (95% cred. int. 2–21.6) | NA | 49.4 (95% cred. int.: 40.4–60.4) |